Merck KGaA names new life science chief; Clyde raises €2M; Reuters gives a thumbs-up to AstraZeneca;

@FierceBiotech: Galapagos' closely-watched rheumatoid arthritis drug filgotinib scores in PhIIb. Report | Follow @FierceBiotech

@JohnCFierce: Meanwhile, back in biotech boomland, Aduro prices at $17 a share. Over the range
$ADRO. Reuters story | Follow @JohnCFierce

> Merck KGaA has named Udit Batra as the new head of its life sciences division, following the $17 billion Sigma-Aldrich buyout. Story

> Clyde Biosciences has rounded up a £2 million Series A investment. The round was led by Epidarex Capital, with contributions from Scottish Enterprise's investment arm, the Scottish Investment Bank and Glasgow University Holdings. Release

> Senior Reuters writer Ben Hirschler gives AstraZeneca ($AZN) and CEO Pascal Soriot high marks for reorganizing the company as key franchises lose patent protection. Story

Medical Device News

@FierceMedDev: EarlySense nabs Mitsui as Japan partner, investor and ups financing to $25M. Article | Follow @FierceMedDev

@VarunSaxena2: ICYMI yesterday: Medtronic joins St. Jude in leadless pacemaker market thanks to CE mark. Report | Follow @VarunSaxena2

@EmilyWFierce: Visual app acts as a "cheat sheet" for docs looking for a quick diagnosis. Wired story | Follow @EmilyWFierce

> Startup raises $4M for sterilization with vaporized hydrogen peroxide. More

> Baxter expanding its manufacturing plant in Arkansas amid preparations to spin off pharma biz. Story

Pharma News

@FiercePharma: ICYMI yesterday: Merck's Frazier joins top-paid pharma CEOs with a $25M package. Article | Follow @FiercePharma

@EricPFierce: Sounds like Walgreens would like to buy into another drug distributor like AmerisourceBergen. FiercePharmaManufacturing story | Follow @EricPFierce

@CarlyHFierce: The coming generics threat to Pfizer's Viagra brand just got scarier. FiercePharmaMarketing report | Follow @CarlyHFierce

> Congress spurs feds to investigate sky-high generic drug prices. News

> Novartis has fresh data to support newly acquired CLL drug Arzerra. Article

> Onglyza's label should flag heart failure risks, FDA panel says. Story

Pharma Marketing News

> Eisai rejig means sales-force downsizing at a critical moment for Arena's Belviq. More

> Tech it out: Pfizer, AARP and UnitedHealthcare push innovation. Report

> J&J's Invokana fends off new SGLT2 rivals to hit $278M in Q1. More

> DTC ad viewers really do ask their doctors about new meds, survey finds. Story

> The coming generics threat to Pfizer's Viagra brand just got scarier. Article

Biotech Research News

> Focused on cell signaling, CHOP team preps for human mitochondrial drug study. Report

> UCLA team packs large cargo into cells. Item

> Scripps Parkinson's study points to a key enzyme as a potential drug target. More

> MIT team works on amping up a new approach to cancer immunotherapies. Story

> Chicago project highlights effects of an ancient Chinese cardio remedy. Article

Diagnostics News

> GE and Veracyte team up for disease diagnostic research collaboration. Item

> NIH awards $11M to develop tests for drug-resistant bacteria. Story

> FDA announces LuSys Labs' recall of its unapproved Ebola diagnostic. More

> Roche grabs CAPP Medical to gain ground in cancer Dx. News

> Biocartis joins forces with Microbiome for quick sepsis test. Article